Abbott Laboratories is to spend a85m and expand its pharmaceutical manufacturing facility in Sligo (Ireland), saying that would help the company to ensure its supply of compounds in biopharmaceutical areas like virology and nephrology. The investment, which will result in the creation of up to 175 jobs, is supported by the country’s investment promotion agency IDA Ireland. The expansion will be completed in 2014, bringing total employment at the site to 300. Azita Saleki-Gerhardt, president of global pharmaceutical operations at Abbott, said the company has had a presence in Ireland for more than 65 years, and that Sligo is an important part of its pharmaceutical manufacturing network. In total, Abbott runs eight manufacturing facilities in Ireland.